Correlation Between Vaccinex and Bristol Myers

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Vaccinex and Bristol Myers at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vaccinex and Bristol Myers into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vaccinex and Bristol Myers Squibb, you can compare the effects of market volatilities on Vaccinex and Bristol Myers and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vaccinex with a short position of Bristol Myers. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vaccinex and Bristol Myers.

Diversification Opportunities for Vaccinex and Bristol Myers

-0.63
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Vaccinex and Bristol is -0.63. Overlapping area represents the amount of risk that can be diversified away by holding Vaccinex and Bristol Myers Squibb in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bristol Myers Squibb and Vaccinex is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vaccinex are associated (or correlated) with Bristol Myers. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bristol Myers Squibb has no effect on the direction of Vaccinex i.e., Vaccinex and Bristol Myers go up and down completely randomly.

Pair Corralation between Vaccinex and Bristol Myers

Given the investment horizon of 90 days Vaccinex is expected to generate 2.69 times less return on investment than Bristol Myers. In addition to that, Vaccinex is 3.01 times more volatile than Bristol Myers Squibb. It trades about 0.02 of its total potential returns per unit of risk. Bristol Myers Squibb is currently generating about 0.19 per unit of volatility. If you would invest  5,264  in Bristol Myers Squibb on August 27, 2024 and sell it today you would earn a total of  623.00  from holding Bristol Myers Squibb or generate 11.84% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Vaccinex  vs.  Bristol Myers Squibb

 Performance 
       Timeline  
Vaccinex 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Vaccinex has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.
Bristol Myers Squibb 

Risk-Adjusted Performance

13 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Bristol Myers Squibb are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak primary indicators, Bristol Myers showed solid returns over the last few months and may actually be approaching a breakup point.

Vaccinex and Bristol Myers Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Vaccinex and Bristol Myers

The main advantage of trading using opposite Vaccinex and Bristol Myers positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vaccinex position performs unexpectedly, Bristol Myers can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bristol Myers will offset losses from the drop in Bristol Myers' long position.
The idea behind Vaccinex and Bristol Myers Squibb pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..

Other Complementary Tools

CEOs Directory
Screen CEOs from public companies around the world
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Technical Analysis
Check basic technical indicators and analysis based on most latest market data